Your session is about to expire
← Back to Search
COVID-19 Positive Participants for COVID-19
N/A
Waitlist Available
Led By Ellen Wald, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 study visit (data collected in 20 seconds)
Awards & highlights
Study Summary
This trial will compare how saliva and nose swab samples collect COVID-19 data in 225 patients over 6 months at a Madison hospital.
Eligible Conditions
- COVID-19
- Coronavirus
- Diagnostic Test
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 study visit (data collected in 20 seconds)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 study visit (data collected in 20 seconds)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Sensitivity: True Positive Rate
Tabulated Results From Nasopharyngeal (NP) vs Lollipop Swab-based PCR Covid-19 Tests
Secondary outcome measures
Number of Participants With Discordant Test Results
Summary of COVID-19 Clinical Characteristics by Discordant Results
Summary of COVID-19 Clinical Characteristics by Participant Count
Trial Design
1Treatment groups
Experimental Treatment
Group I: COVID-19 Positive ParticipantsExperimental Treatment1 Intervention
Determined by NP PCR test
Find a Location
Who is running the clinical trial?
University of Wisconsin, MadisonLead Sponsor
1,193 Previous Clinical Trials
3,161,822 Total Patients Enrolled
14 Trials studying COVID-19
1,667,188 Patients Enrolled for COVID-19
Ellen Wald, MDPrincipal InvestigatorUW School of Medicine and Public Health
1 Previous Clinical Trials
1 Trials studying COVID-19
Share this study with friends
Copy Link
Messenger